Date: May 24, 2023
Time: 8:00 AM (PDT), 11:00 AM (EDT), 5:00 PM (CEST)
Recent advances in multi-omic approaches, including genomics, transcriptomics, and proteomics, enable a more comprehensive description of the tumor. This promises to accelerate the development of precision medicine, but also presents challenges for diagnostic laboratories struggling to integrate this complex workflow into an efficient, scalable and robust service offering. This talk will highlight best practices, systems and innovations necessary for successful implementation of a Comprehensive Genomic and Immune Profiling (CGIP) assay to advance molecularly informed treatment decisions for cancer patients.
- Challenges and opportunities in providing precision treatment options for advanced stage cancer patients
- Innovations leading to broad-panel NGS-based tumor profiling and actionable data for better treatment decision making
- Understand the clinical utility of Comprehensive Genomic and Immune Profiling (CGIP) with a review of 10,000 real-world cases
Webinars will be available for unlimited on-demand viewing after live event.